| Symbol | BMYMP |
|---|---|
| Name | BRISTOL-MYERS SQUIBB CO. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | - |
| Address | 08543 United States NJ Route 206 & Province Line Road |
| Telephone | (609) 252-4621 |
| Fax | — |
| — | |
| Website | http://www.bms.com |
| Incorporation | US |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0000014272 |
| Description | Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power. Additional info from NASDAQ: |
Hickey Benjamin 🟢 acquired 28.6K shares (2 derivative) of BRISTOL MYERS SQUIBB CO (BMY) Transaction Date: Mar 10, 2026 | Filing ID: 000006
Read moreShibutani Hiroshi Chris 🟢 acquired 19.6K shares (2 derivative) of BRISTOL MYERS SQUIBB CO (BMY) Transaction Date: Mar 10, 2026 | Filing ID: 000002
Read moreMassacesi Cristian 🟢 acquired 65.3K shares (2 derivative) of BRISTOL MYERS SQUIBB CO (BMY) Transaction Date: Mar 10, 2026 | Filing ID: 000002
Read morePlenge Robert M 🟡 adjusted position in 33.1K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000002
Read moreMeyers Gregory Scott 🟡 adjusted position in 48.3K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000004
Read moreLenkowsky Adam 🟡 adjusted position in 64.3K shares (6 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000002
Read moreHoch Lynelle 🟡 adjusted position in 11.6K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000002
Read moreGallman Cari 🟡 adjusted position in 60.4K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000003
Read morePoole Ahn Amanda 🟡 adjusted position in 33.8K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000002
Read moreElkins David V 🟡 adjusted position in 47.0K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000002
Read more